ELIQUIS 2.5 mg/1

ELIQUIS 2.5 mg is an oral medication containing apixaban, used for blood clot prevention and treatment. This film-coated tablet is manufactured by E.R. Squibb & Sons, L.L.C. in the USA.

ELIQUIS 2.5 mg is commonly prescribed to reduce the risk of blood clots in conditions like atrial fibrillation. It is also used to treat deep vein thrombosis and pulmonary embolism. The medication works by inhibiting certain clotting factors in the blood, helping to prevent clot formation. Patients often ask, 'What is ELIQUIS used for?' and the answer includes preventing strokes and managing clotting disorders.

Common effects of ELIQUIS 2.5 mg may include bruising, bleeding, and nausea. Some users report dizziness or fatigue. These effects vary among individuals and are not experienced by everyone. It's important to consult a healthcare provider for personalized advice.

ELIQUIS 2.5 mg should be handled with care, especially by those with a history of bleeding disorders. It is crucial to follow the prescribed dosage and storage instructions. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

ELIQUIS 2.5 mg may interact with other blood thinners, certain antibiotics, and antifungal medications. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.